Arizona Tribune - Boulevard

NYSE - LSE

RBGPF	-19.57%	69	$
GSK	-0.26%	58.21	$
AZN	-0.47%	204.03	$
RELX	-0.12%	33.3	$
BTI	-0.07%	58.81	$
RIO	1.15%	98.26	$
NGG	-0.03%	90.29	$
CMSC	0.18%	22.43	$
RYCEF	-1.59%	16.96	$
CMSD	0.18%	22.63	$
BCC	-0.51%	80.17	$
VOD	-1.02%	15.69	$
BCE	-2.31%	23.35	$
JRI	0.31%	13.02	$
BP	1.16%	46.44	$

Featured

In fiery speech, Pope Leo says 'Enough to war!'

Pope Leo lashed out against warmongers on Saturday while calling on billions of people around the globe to embrace peace and "believe once again in love, moderation and good politics".

Benin leans into painful past to attract tourists

Tourists crowded beneath the Door of No Return, an arch built by the beach at Ouidah in southern Benin in memory of those crammed onto slave ships bound for the New World.

Last news

Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease

Expansion improves access to treatment options within periodontal care and helps strengthen partnerships with dental professionals within these populations.

TailorMed Showcases Innovative Patient-Facing Solution at Becker's Fall Chief Pharmacy Officer Summit

TailorMed Connect Gives Patients Direct Access to Critical Support While Scaling Health Systems' Impact

CelLBxHealth PLC Presents Proof-of-Concept Study

CelLBxHealth presents proof-of-concept study using Roche Tissue Diagnostics' workflow at world-leading drug development conferenceParsortix platform shown to be compatible with the Roche BenchMark ULTRA automated staining system, with initial study of three key drug targets: HER2 (breast), TROP2 (lung) and PSMA (prostate)

Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities

Group revenues of € 535.1 m ((7.1)%); Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand;Just - Evotec Biologics ("JEB"; +11.3%) above-expectation; further accelerating growth on non-Sandoz / non-DOD businessStrong scientific advancements of co-developed asset pipeline: Expecting up to four molecules in clinical phase II in next six to nine monthsSigning of landmark industry transaction with Sandoz on 04 November, resulting in payments potentially over US$ 650 m plus royalties on portfolio of up to 10 biosimilar molecules2025 guidance and 2028 outlook confirmed

Coca-Cola Europacific Partners plc Announces Q3 Trading Update & Interim Dividend Declaration

UXBRIDGE, ENGLAND / ACCESS Newswire / November 5, 2025 / Trading Update for the Third Quarter ended 26 September 2025 & Interim Dividend Declaration

Reeling from earthquakes, Afghans fear coming winter

Survivors of a powerful earthquake that turned homes in Afghanistan into rubble are now wondering where they can they find shelter from pouring rain and the coming winter cold.

Munich's surfers stunned after famed river wave vanishes

A standing wave in a Munich stream that has been a surfing magnet for more than four decades has vanished, leaving urban surfers high and dry.

Divisive Czech cardinal Dominik Duka dies at 82

Czech cardinal Dominik Duka, who was accused of covering up clergy sex crimes, died aged 82 on Tuesday, the Prague Archbishopric said on Facebook.

National hero proposal for Indonesia's Suharto sparks backlash

A proposal to include Indonesia's former military dictator Suharto on a list of national heroes sparked opposition from rights advocates who on Tuesday called the nomination a "betrayal".

Indian Sikh pilgrims enter Pakistan, first major crossing since May conflict: AFP

Pakistan on Tuesday welcomed dozens of Sikh pilgrims from India, AFP journalists saw, in the first major crossing since deadly clashes in May closed the land border between the nuclear-armed neighbours.

Nintendo hikes Switch 2 annual unit sales target

Nintendo said Tuesday it aims to sell 19 million Switch 2 consoles within this financial year, up from its previous target 15 million for the smash-hit gadget.

Typhoon flooding kills 5, strands thousands in central Philippines

At least five people have been killed and hundreds of thousands displaced as rains driven by Typhoon Kalmaegi flooded swathes of the central Philippines on Tuesday.

US civil trial to hear opening arguments on Boeing MAX crash

Lawyers for US aviation giant Boeing and the families of victims of a fatal Ethiopian Airlines crash will give opening statements Tuesday in the first civil trial stemming from the disaster.

Myanmar scam hub sweep triggers fraudster recruitment rush

Recent raids on one of Myanmar's most notorious internet scam hubs sparked a recruitment rush as fleeing workers scrambled to enlist at nearby fraud factories, experts and insiders told AFP.

Floods strand people on roofs as typhoon pounds Philippines

Residents sought refuge on rooftops and cars floated through flooded streets on Tuesday as Typhoon Kalmaegi battered the central Philippines, leaving at least two people dead.

In Morocco, exiled Afghan women footballers find hope on the pitch

Manoozh Noori said she "wanted to die" when the Taliban returned to power in Afghanistan in 2021. That meant she could no longer do what she loved most: playing football.

Why an Amazon chef said no to a vegan dinner for Prince William event

Saulo Jennings, a chef from Brazil's Amazon region, is so passionate about the rainforest's flavors -- like the massive pirarucu fish -- that he refused to cater a vegan dinner at an environmental awards ceremony hosted by Britain's Prince William.

Cement maker Lafarge on trial in France on charges of funding jihadists

Cement group Lafarge goes on trial in France Tuesday, accused of paying the Islamic State group and other jihadists protection money to build its business in war-torn Syria.

Worker dies after medieval tower partly collapses in Rome

A worker who was pulled from the rubble of a medieval tower that partly collapsed in Rome died on Tuesday, Italian media reported citing hospital sources.

Final Moment Launches Groundbreaking Digital Memorial Platform to Redefine Legacy Preservation and Posthumous Communication

NAPERVILLE, IL / ACCESS Newswire / November 4, 2025 / Final Moment, a technology company focused on transforming how people preserve memories and communicate beyond life, has officially announced the launch of its innovative online memorial platform. Designed for individuals and families seeking a modern approach to legacy creation, the platform empowers users to record, schedule, and share meaningful messages, images, and stories that endure long after they are gone.

Electronic Caregiver Brings Addison Virtual Care Platform to the Annual Session & Primary Care Summit 2025 in Addison, Texas

Addison enables continuous patient oversight, early intervention, and intelligent adherence through customizable RPM/CCM integration.

President Trumps Two Wars: Drug Cartels Abroad, Marijuana Science at Home - We Must Win Both

The DEA's Double Standard: Raiding Cartels While Blocking CuresThe time has come for Cole's DEA to separate crime from science, ending the seven year blockade on medical cannabis and proving that true public safety includes curing disease, not just seizing drugs.

Mosaic Announces Third Quarter 2025 Results

TAMPA, FL / ACCESS Newswire / November 4, 2025 / The Mosaic Company (NYSE:MOS) released its financial results for the third quarter of 2025. The company's earnings release and supplemental materials are available at https://investors.mosaicco.com/financials/quarterly-results.

Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth

Zomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter!

Newsmax to Attend the RBC Capital Markets Global Technology, Internet, Media & Telecommunications Conference

BOCA RATON, FL / ACCESS Newswire / November 4, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced that management, including CEO Christopher Ruddy, will attend the RBC Capital Markets Global Technology, Internet, Media & Telecommunications Conference being held in New York City from November 18-19, 2025.

Strive Pharmacy Expands Footprint with Acquisition of Alachua Facility and New Tampa Location, Cementing Leadership in Patient-Focused Compounding Innovation

With more than 700,000 square feet of advanced operations within the next 12 months, Strive solidifies its position as a national leader in pharmaceutical compounding while pursuing its mission to elevate patient care through innovation, scale, and quality.

Exousia Pro Announces Breakthrough In Exosome-Based Delivery

Successful loading of CBD material accelerates the path to revenue.

FLEX(C) Launches TRACK-LOCK(TM) Wall-Mount Storage System At The 2025 SEMA Show

LAS VEGAS, NV / ACCESS Newswire / November 4, 2025 / During the 2025 SEMA Show, FLEX© is transforming the detailing workspace with the launch of its TRACK-LOCK™ wall-mount storage system.

Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend

SALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors. Mr. Timken, who served as UTMD's outside legal counsel for over twenty years prior to his retirement in 2025, graduated with a J.D. degree from the University of Utah College of Law in 1997. The Board believes his robust understanding of the functional and strategic challenges that the Company faces will be integral for continuing UTMD's future excellent performance.

SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development

CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 4, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gene Editing and Cell Engineering is pleased to acknowledge recent FDA commentary and industry analyses signaling continued evolution of regulatory pathways for genome-editing technologies. These developments highlight increasing regulatory focus on precision-engineered genetic tools, non-viral delivery approaches, and scalable manufacturing frameworks.

CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference

SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / November 4, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential best-in-class, anti-CD38 monoclonal antibody for patients with organ transplant rejection and autoimmune diseases, today announced that the CASI management team will participate at the Guggenheim Healthcare Innovation Conference 2025 in a fireside chat at 9:30 AM ET on November 12 in Boston, MA. CASI will also host one-on-one meetings with investors at the conference.

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results

Revenues increased 57% for the quarter and 38% for the six months ended September 30, 2025 compared to same periods last yearU.S. revenue increased 115% for the quarter and 86% for the six months ended September 30, 2025 compared to same periods last yearNet loss per share decreased 46% for the quarter and 42% for the six months ended September 30, 2025 compared to same periods last year

Arizona Tribune - Boulevard (English)